Pfizer Dilantin
Executive Summary
Chewable 50 mg tablets for infants in short supply due to manufacturing problems, the company said. Pfizer is advising physicians that the suspension formulation of phenytoin may be substituted for the chewable tablets. Production of Dilantin has been plagued by dissolution problems. The latest recall of the product was in June 1999